高爭民爆(002827.SZ):收購成遠礦業51%股權獲控股股東批覆
格隆匯11月1日丨高爭民爆(002827.SZ)公佈,2019年10月30日,公司收到控股股東西藏高爭建材集團出具的《關於對收購成遠礦業開發股份有限公司51%股權的批覆》,控股股東原則同意公司以支付現金方式向羅乃鑫等52名交易對方收購其持有的成遠礦業開發股份有限公司(“成遠股份”)1750.4391萬股股權,收購金額合計7579.40萬元;同時以現金向成遠股份增資1645.7840萬股,增資金額合計7126.24萬元;收購及增資金額共計約1.47億元,收購及增資完成後公司持有成遠股份51%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.